Catalyst Pharma

$13.13 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Catalyst Pharma

Catalyst Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on the development and commercialization of therapies for people with debilitating diseases. Catalyst Pharmaceuticals serves customers in the United States.

Stock Analysis

last close $10.6
1-mo return 40.2%
3-mo return 62.1%
avg daily vol. 2.15M
52-week high 11.32
52-week low 4.81
market cap. $1.1B
forward pe 14.4
annual div. -
roe 22.6%
ltg forecast -
dividend yield -
annual rev. $154M
inst own. 71.4%
baraka

Subscribe now for daily local and international financial news

Subscribe